
Chemical and Pharmaceutical Bulletin p. 1532 - 1537 (1999)
Update date:2022-07-31
Topics:
Akasaka, Kozo
Komatsu, Yuki
Tagami, Katsuya
Shimizu, Toshikazu
Shimomura, Naoyuki
Naka, Hiroshi
Hayashi, Kenji
Negi, Shigeto
An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)- Methyl-6-oxopipecolic acid ester (3a), prepared from L-α,-aminoadipic acid, was chemoselectively reduced to the
View MoreHangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Xinxiang Junlong Biological Technology Co., Ltd.
website:https://junlongbio.lookchem.com/
Contact:86-13525059581
Address:Xinxiang City, Henan Province
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Lanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
Doi:10.1016/j.molstruc.2012.12.018
(2013)Doi:10.3109/14756366.2011.653355
(2013)Doi:10.1039/c3ra41640b
(2013)Doi:10.1021/ol400493x
(2013)Doi:10.1016/j.jorganchem.2013.01.013
(2013)Doi:10.1021/om400025h
(2013)